ATAI
Price
$2.21
Change
-$0.00 (-0.00%)
Updated
Jun 26, 01:09 PM (EDT)
Capitalization
463.64M
53 days until earnings call
DAO
Price
$8.43
Change
-$0.32 (-3.66%)
Updated
Jun 26, 01:14 PM (EDT)
Capitalization
499.34M
49 days until earnings call
Interact to see
Advertisement

ATAI vs DAO

Header iconATAI vs DAO Comparison
Open Charts ATAI vs DAOBanner chart's image
ATAI Life Sciences
Price$2.21
Change-$0.00 (-0.00%)
Volume$23.69K
Capitalization463.64M
Youdao
Price$8.43
Change-$0.32 (-3.66%)
Volume$100
Capitalization499.34M
ATAI vs DAO Comparison Chart in %
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DAO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. DAO commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Buy and DAO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (ATAI: $2.20 vs. DAO: $8.55)
Brand notoriety: ATAI and DAO are both not notable
ATAI represents the Biotechnology, while DAO is part of the Miscellaneous Commercial Services industry
Current volume relative to the 65-day Moving Average: ATAI: 90% vs. DAO: 61%
Market capitalization -- ATAI: $463.64M vs. DAO: $499.34M
ATAI [@Biotechnology] is valued at $463.64M. DAO’s [@Miscellaneous Commercial Services] market capitalization is $499.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.49B to $0. The market cap for tickers in the [@Miscellaneous Commercial Services] industry ranges from $80.94B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B. The average market capitalization across the [@Miscellaneous Commercial Services] industry is $5.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileDAO’s FA Score has 0 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • DAO’s FA Score: 0 green, 5 red.
According to our system of comparison, ATAI is a better buy in the long-term than DAO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 4 TA indicator(s) are bullish while DAO’s TA Score has 3 bullish TA indicator(s).

  • ATAI’s TA Score: 4 bullish, 4 bearish.
  • DAO’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ATAI is a better buy in the short-term than DAO.

Price Growth

ATAI (@Biotechnology) experienced а -5.58% price change this week, while DAO (@Miscellaneous Commercial Services) price change was -2.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.78%. For the same industry, the average monthly price growth was +31.36%, and the average quarterly price growth was +15.04%.

The average weekly price growth across all stocks in the @Miscellaneous Commercial Services industry was +0.49%. For the same industry, the average monthly price growth was +2.42%, and the average quarterly price growth was +10.40%.

Reported Earning Dates

ATAI is expected to report earnings on Aug 18, 2025.

DAO is expected to report earnings on Aug 14, 2025.

Industries' Descriptions

@Biotechnology (+1.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Miscellaneous Commercial Services (+0.49% weekly)

The sector produces general business services, and are not classified elsewhere. For example, FleetCor Technologies provides fuel cards and workforce payment products and services; Copart, Inc. provides online vehicle auction and remarketing services across various nations; Equifax Inc. collects and aggregates credit information on consumers and businesses worldwide, along with selling credit monitoring and fraud-prevention services. Many of the companies in this category have multi-billion market capitalizations.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DAO($499M) has a higher market cap than ATAI($464M). ATAI YTD gains are higher at: 65.414 vs. DAO (15.541). ATAI has higher annual earnings (EBITDA): -145.09M vs. DAO (-513.47M). DAO has more cash in the bank: 360M vs. ATAI (98.2M). ATAI has less debt than DAO: ATAI (26.7M) vs DAO (1.54B). DAO has higher revenues than ATAI: DAO (5.36B) vs ATAI (1.86M).
ATAIDAOATAI / DAO
Capitalization464M499M93%
EBITDA-145.09M-513.47M28%
Gain YTD65.41415.541421%
P/E RatioN/AN/A-
Revenue1.86M5.36B0%
Total Cash98.2M360M27%
Total Debt26.7M1.54B2%
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
96
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
14
SEASONALITY SCORE
1..100
87

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATAIDAO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 14 days ago
85%
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DAO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PPTCX16.66N/A
N/A
Virtus KAR Global Quality Dividend C
DIFCX12.30N/A
N/A
MFS Diversified Income C
PJFZX72.85N/A
N/A
PGIM Jennison Growth Z
MDLVX30.51N/A
N/A
BlackRock Advantage Large Cap Val Inv A
TCGCX21.07-0.23
-1.08%
Thornburg Small/Mid Cap Growth C

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with MNMD. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
+4.27%
MNMD - ATAI
54%
Loosely correlated
-4.27%
RXRX - ATAI
46%
Loosely correlated
-1.15%
CRSP - ATAI
46%
Loosely correlated
+1.88%
CYBN - ATAI
46%
Loosely correlated
+5.36%
COUR - ATAI
45%
Loosely correlated
-0.82%
More

DAO and

Correlation & Price change

A.I.dvisor tells us that DAO and ATAI have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DAO and ATAI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DAO
1D Price
Change %
DAO100%
-2.29%
ATAI - DAO
31%
Poorly correlated
+4.27%
ARLO - DAO
29%
Poorly correlated
-0.24%
COUR - DAO
28%
Poorly correlated
-0.82%
BVRDF - DAO
27%
Poorly correlated
N/A
DNB - DAO
26%
Poorly correlated
-0.11%
More